Postoperative pharmacotherapy for patients with biliary atresia in Japan
Background Members of the Japanese Biliary Atresia Society were surveyed using questionnaires that assess their current practice regarding postoperative pharmacotherapy for outpatients with biliary atresia (BA). Methods In September 2018, questionnaires were sent to 100 member institutions of the Ja...
Saved in:
Published in | Pediatric investigation Vol. 64; no. 1; pp. e14990 - n/a |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
John Wiley & Sons, Inc
01.01.2022
Blackwell Publishing Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
Members of the Japanese Biliary Atresia Society were surveyed using questionnaires that assess their current practice regarding postoperative pharmacotherapy for outpatients with biliary atresia (BA).
Methods
In September 2018, questionnaires were sent to 100 member institutions of the Japanese Biliary Atresia Society. Questionnaires included the number of BA outpatients per institution and pharmacotherapy for outpatients with native liver. Pharmacotherapies were categorized into antibiotics, cholagogues, hepatoprotective agents, branched‐chain amino acid supplement, Japanese Kampo medicine, probiotics, laxative, glycerin enema, and “others.” In each category, the questionnaires asked about the medicine's details and the time of withdrawal of administration.
Results
Responses were collected from 58 of the 100 institutions. Fifty‐four institutions (94.7%) had prescribed one or more medicines as postoperative pharmacotherapy, and three institutions (5.3%) did not prescribe any medicines. Fifty‐three institutions (93.0%) had prescribed ursodeoxycholic acid (UDCA), and 32 (60.4%) of these continued prescribing UDCA as long as the condition of patients remained unchanged. Twenty‐nine (50.9%) had prescribed Japanese Kampo medicines (“Inchinkoto” in all cases). Twenty‐four (42.1%) had prescribed antibiotics, mainly trimethoprim‐sulfamethoxazole, in 21 (87.5%). Twenty‐three (40.4%) had prescribed probiotics.
Conclusions
There were many variations of pharmacotherapy in BA outpatients with native liver in Japan, including antibiotic, probiotic, and Inchinkoto prescriptions. Of the various drugs, the most commonly administered was UDCA. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1328-8067 2096-3726 1442-200X 2574-2272 |
DOI: | 10.1111/ped.14990 |